Product
HIVIS DNA + Cervarix and MVA-CMDR
1 clinical trial
1 indication
Indication
HIV InfectionsClinical trial
Phase I, Proof of Concept, Open-Label, Randomized Clinical Trial to Evaluate the Safety and Effects of Using Prime-boost HIVIS DNA and MVA-CMDR Vaccine Regimens With or Without Toll-like Receptor 4 Agonist on HIV Reservoirs in Perinatally HIV Infected Children and YouthStatus: Active (not recruiting), Estimated PCD: 2023-10-16